{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T09:30:15Z","timestamp":1748856615067,"version":"3.40.5"},"posted":{"date-parts":[[2023,12,11]]},"group-title":"In Review","reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,12,7]]},"abstract":"<title>Abstract<\/title>\n        <p>Objective\n To characterize late preterm antenatal steroids (AS) use and associated neonatal outcomes in a single academic center.\nStudy Design\n Retrospective study of 503 singleton, mother-infant dyads delivered between 34 0\/7 to 36 6\/7 weeks gestation between January 1, 2016 to December 31, 2020.\nResults\n 43% did not receive AS (No AS) prior to delivery. Among AS treated, 50% were sub-optimal dosing. No AS had higher preterm premature rupture of membranes and maternal diabetes. AS group had lower mean gestational age and birthweight and longer time from admission to delivery and longer NICU study. There was no difference in neonatal hypoglycemia.\nConclusions\n Sub-optimal AS dosing in late preterms remains high in our center. AS did not improve neonatal outcomes. Studies are needed to evaluate the impact of AS in diabetics delivering late preterm, to optimize the timing of AS dosing, and evaluate the longer term impact on late preterm infants.<\/p>","DOI":"10.21203\/rs.3.rs-3718685\/v1","type":"posted-content","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T14:30:26Z","timestamp":1702305026000},"source":"Crossref","is-referenced-by-count":1,"title":["Late Preterm Antenatal Steroid Use and Infant Outcomes in a Single Center"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7098-3223","authenticated-orcid":false,"given":"Mitzi","family":"Go","sequence":"first","affiliation":[{"name":"Oregon Health & Science University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison","family":"Wahl","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tova","family":"Kruss","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8501-8813","authenticated-orcid":false,"given":"Cindy","family":"McEvoy","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"year":"2021","author":"Reddy UM","unstructured":"Society for Maternal-Fetal Medicine. Electronic address pso, Reddy UM, Deshmukh U, Dude A, Harper L, Osmundson SS. Society for Maternal-Fetal Medicine Consult Series #58: Use of antenatal corticosteroids for individuals at risk for late preterm delivery: Replaces SMFM Statement #4, Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016. American journal of obstetrics and gynecology. 2021;225(5):B36-B42.","key":"ref1"},{"issue":"2","key":"ref2","first-page":"e102-e9","article-title":"713: Antenatal Corticosteroid Therapy for Fetal Maturation","volume":"130","author":"Committee on Obstetric P. Committee Opinion No","year":"2017","unstructured":"Committee on Obstetric P. Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstet Gynecol. 2017;130(2):e102-e9.","journal-title":"Obstet Gynecol"},{"issue":"14","key":"ref3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","article-title":"Antenatal Betamethasone for Women at Risk for Late Preterm Delivery","volume":"374","author":"Gyamfi-Bannerman C","year":"2016","unstructured":"Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita AT, Reddy UM, Saade GR, et al. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. N Engl J Med. 2016;374(14):1311\u201320.","journal-title":"N Engl J Med"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41372-020-0589-1","article-title":"Neonatal hypoglycemia after initiation of late preterm antenatal corticosteroids","volume":"40","author":"Uquillas KR","year":"2020","unstructured":"Uquillas KR, Lee RH, Sardesai S, Chen E, Ihenacho U, Cortessis VK, et al. Neonatal hypoglycemia after initiation of late preterm antenatal corticosteroids. Journal of perinatology: official journal of the California Perinatal Association. 2020;40(9):1339\u201348.","journal-title":"Journal of perinatology: official journal of the California Perinatal Association"},{"issue":"4","key":"ref5","first-page":"R825-R39","article-title":"Efficacy and safety of antenatal steroids","volume":"315","author":"Kemp MW","year":"2018","unstructured":"Kemp MW, Jobe AH, Usuda H, Nathanielsz PW, Li C, Kuo A, et al. Efficacy and safety of antenatal steroids. Am J Physiol Regul Integr Comp Physiol. 2018;315(4):R825-R39.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"e0248774","DOI":"10.1371\/journal.pone.0248774","article-title":"Antenatal corticosteroids for impending late preterm (34\u201336\u2009+\u20096 weeks) deliveries-A systematic review and meta-analysis of RCTs","volume":"16","author":"Deshmukh M","year":"2021","unstructured":"Deshmukh M, Patole S. Antenatal corticosteroids for impending late preterm (34\u201336\u2009+\u20096 weeks) deliveries-A systematic review and meta-analysis of RCTs. PLoS One. 2021;16(3):e0248774.","journal-title":"PLoS One"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"e2228518","DOI":"10.1001\/jamanetworkopen.2022.28518","article-title":"Associations Between Maternal Antenatal Corticosteroid Treatment and Psychological Developmental and Neurosensory Disorders in Children","volume":"5","author":"Raikkonen K","year":"2022","unstructured":"Raikkonen K, Gissler M, Tapiainen T, Kajantie E. Associations Between Maternal Antenatal Corticosteroid Treatment and Psychological Developmental and Neurosensory Disorders in Children. JAMA Netw Open. 2022;5(8):e2228518.","journal-title":"JAMA Netw Open"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"101285","DOI":"10.1016\/j.eclinm.2022.101285","article-title":"Antenatal dexamethasone for late preterm birth: A multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial","volume":"44","author":"Collaborators WAT","year":"2022","unstructured":"Collaborators WAT. Antenatal dexamethasone for late preterm birth: A multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial. EClinicalMedicine. 2022;44:101285.","journal-title":"EClinicalMedicine"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1667028","article-title":"Practice Variation in Antenatal Steroid Administration for Anticipated Late Preterm Birth: A Physician Survey","volume":"36","author":"Battarbee AN","year":"2019","unstructured":"Battarbee AN, Clapp MA, Boggess KA, Kaimal A, Snead C, Schulkin J, et al. Practice Variation in Antenatal Steroid Administration for Anticipated Late Preterm Birth: A Physician Survey. American journal of perinatology. 2019;36(2):200\u20134.","journal-title":"American journal of perinatology"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1055\/a-1785-9290","article-title":"Indication Creep of Antenatal Late Preterm Steroids","volume":"39","author":"McElwee ER","year":"2022","unstructured":"McElwee ER, Wilkinson K, Crowe R, Newman JC, Alkis M, Wineland R, et al. Indication Creep of Antenatal Late Preterm Steroids. American journal of perinatology. 2022;39(11):1159\u201365.","journal-title":"American journal of perinatology"},{"issue":"2","key":"ref11","first-page":"e49-e64","article-title":"190: Gestational Diabetes Mellitus","volume":"131","author":"ACOG Practice Bulletin No","year":"2018","unstructured":"ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol. 2018;131(2):e49-e64.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ppul.1070","article-title":"Functional residual capacity and passive compliance measurements after antenatal steroid therapy in preterm infants","volume":"31","author":"McEvoy C","year":"2001","unstructured":"McEvoy C, Bowling S, Williamson K, Stewart M, Durand M. Functional residual capacity and passive compliance measurements after antenatal steroid therapy in preterm infants. Pediatric pulmonology. 2001;31(6):425\u201330.","journal-title":"Pediatric pulmonology"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1067\/mob.2000.108876","article-title":"Timing of antenatal corticosteroids and neonatal pulmonary mechanics","volume":"183","author":"McEvoy C","year":"2000","unstructured":"McEvoy C, Bowling S, Williamson K, Collins J, Tolaymat L, Maher J. Timing of antenatal corticosteroids and neonatal pulmonary mechanics. American journal of obstetrics and gynecology. 2000;183(4):895\u20139.","journal-title":"American journal of obstetrics and gynecology"},{"issue":"2 Pt 1","key":"ref14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1542\/peds.110.2.280","article-title":"The effect of a single remote course versus weekly courses of antenatal corticosteroids on functional residual capacity in preterm infants: a randomized trial","volume":"110","author":"McEvoy C","year":"2002","unstructured":"McEvoy C, Bowling S, Williamson K, Lozano D, Tolaymat L, Izquierdo L, et al. The effect of a single remote course versus weekly courses of antenatal corticosteroids on functional residual capacity in preterm infants: a randomized trial. Pediatrics. 2002;110(2 Pt 1):280\u20134.","journal-title":"Pediatrics"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"544 e1-9","DOI":"10.1016\/j.ajog.2010.01.038","article-title":"Respiratory compliance in preterm infants after a single rescue course of antenatal steroids: a randomized controlled trial","volume":"202","author":"McEvoy C","year":"2010","unstructured":"McEvoy C, Schilling D, Peters D, Tillotson C, Spitale P, Wallen L, et al. Respiratory compliance in preterm infants after a single rescue course of antenatal steroids: a randomized controlled trial. American journal of obstetrics and gynecology. 2010;202(6):544 e1-9.","journal-title":"American journal of obstetrics and gynecology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpeds.2018.05.037","article-title":"Respiratory Compliance in Late Preterm Infants (34(0\/7)-34(6\/7) Weeks) after Antenatal Steroid Therapy","volume":"201","author":"Go M","year":"2018","unstructured":"Go M, Schilling D, Nguyen T, Durand M, McEvoy CT. Respiratory Compliance in Late Preterm Infants (34(0\/7)-34(6\/7) Weeks) after Antenatal Steroid Therapy. The Journal of pediatrics. 2018;201:21\u20136.","journal-title":"The Journal of pediatrics"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/adc.2003.039412","article-title":"Neurodevelopmental outcome of hypoglycaemia in healthy, large for gestational age, term newborns","volume":"90","author":"Brand PL","year":"2005","unstructured":"Brand PL, Molenaar NL, Kaaijk C, Wierenga WS. Neurodevelopmental outcome of hypoglycaemia in healthy, large for gestational age, term newborns. Arch Dis Child. 2005;90(1):78\u201381.","journal-title":"Arch Dis Child"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1542\/peds.2007-2822","article-title":"Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia","volume":"122","author":"Burns CM","year":"2008","unstructured":"Burns CM, Rutherford MA, Boardman JP, Cowan FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics. 2008;122(1):65\u201374.","journal-title":"Pediatrics"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0022-3476(99)70209-X","article-title":"Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational-age preterm infants","volume":"134","author":"Duvanel CB","year":"1999","unstructured":"Duvanel CB, Fawer CL, Cotting J, Hohlfeld P, Matthieu JM. Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational-age preterm infants. The Journal of pediatrics. 1999;134(4):492\u20138.","journal-title":"The Journal of pediatrics"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"e265-72","DOI":"10.1542\/peds.2012-0079","article-title":"Neonatal morbidities and developmental delay in moderately preterm-born children","volume":"130","author":"Kerstjens JM","year":"2012","unstructured":"Kerstjens JM, Bocca-Tjeertes IF, de Winter AF, Reijneveld SA, Bos AF. Neonatal morbidities and developmental delay in moderately preterm-born children. Pediatrics. 2012;130(2):e265-72.","journal-title":"Pediatrics"},{"issue":"6659","key":"ref21","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.297.6659.1304","article-title":"Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia","volume":"297","author":"Lucas A","year":"1988","unstructured":"Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. BMJ. 1988;297(6659):1304\u20138.","journal-title":"BMJ"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jpeds.2011.12.047","article-title":"Hypoglycemia is associated with increased risk for brain injury and adverse neurodevelopmental outcome in neonates at risk for encephalopathy","volume":"161","author":"Tam EW","year":"2012","unstructured":"Tam EW, Haeusslein LA, Bonifacio SL, Glass HC, Rogers EE, Jeremy RJ, et al. Hypoglycemia is associated with increased risk for brain injury and adverse neurodevelopmental outcome in neonates at risk for encephalopathy. The Journal of pediatrics. 2012;161(1):88\u201393.","journal-title":"The Journal of pediatrics"},{"issue":"6","key":"ref23","first-page":"e1497-503","article-title":"15-year follow-up of recurrent \"hypoglycemia\" in preterm infants","volume":"130","author":"Tin W","year":"2012","unstructured":"Tin W, Brunskill G, Kelly T, Fritz S. 15-year follow-up of recurrent \"hypoglycemia\" in preterm infants. Pediatrics. 2012;130(6):e1497-503.","journal-title":"Pediatrics"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3718685\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3718685\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T07:11:20Z","timestamp":1710832280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3718685\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":23,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3718685\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41372-024-01934-2","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,12,11]]},"subtype":"preprint"}}